Transnasal Trasnssphenoidal Surgery for Pituitary Tumours

Authors

  • FAROOQ AZAM Pak International Medical Science, Khyber Pakhtoonkhawa
  • MIAN IFTIKHAR UL HAQ Pak International Medical Science, Khyber Pakhtoonkhawa
  • MUHAMMAD TARIQ SAFI Pak International Medical Science, Khyber Pakhtoonkhawa

Keywords:

Transnasal transsphenoidal surgery, ituitary adenomas

Abstract

Objective: To determine the frequency of early post-operatively complications of transnasal transsphenoidal surgery for pituitary adenoma.
Study design: Descriptive study.
Place and Duration of Study: Pak International Medical Science Khyber Pakhtoonkhawa from 1st February 2008 to 31st July 2011.
Material and methods: A total 41 patients with pituitary adenoma fulfilling the inclusion and exclusion criteria were included in this study. All patients were undergone transnasal transsphenoidal surgery. These patients were followed up for early complications of transsphenoidal surgery for one month.
Results: Out of 41 patients, there were 23 (56.09%) males and 18 (43.9%) females. The age of patients ranged from 10 to 70 years. In this study the overall mean age was 44.75 years. Majority of patients fourteen (34.14%) were in the age range of 41 – 50 years, followed by eleven (26.8%) patients in age group of 31 – 40 years, seven (17.07%) patients were in the age range of 51 – 60 years, five (12.1%) in the age range of 61 – 70 years, three (7.31%) in the age group of 21 – 30 years and one (2.4%) in the age group of 10 – 20 years. Early post-operative complications were diabetes insipidus in four (7.31%) patients, CSF leak two (4.87%) patients, meningitis in one (2.43%) patient and epistaxis in one (2.43%) patient.
Conclusions: Surgical complications of Transnasal transsphenoidal surgery are minimal. Transnasal trans-sphenoidal surgery is a safe and effective treatment for pituitary tumour.

References

1. Murad MH, Fernández – Balsells MM et al. Outcomes of surgical treatment for nonfunctioning pituitary ade-nomas: a systematic review and meta – analysis. Clin Endocrinol 2010 Dec; 73: 777-91.
2. Shahlaie K, McLaughlin N, Kassam AB, Kelly DF. The role of outcomes data for assessing the expertise of a pituitary surgeon. Curr Opin Endocrinol Diabetes Obes 2010; 17: 369-76.
3. Ausiello JC, Bruce JN, Freda PU. Postoperative assess-ment of the patient after transsphenoidal pituitary sur-gery. Pituitary 2008; 11: 391-401.
4. Dehdashti AR, Ganna A, Karabatsou K, Gentili F. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 2008; 62: 1006-15.
5. Higgins TS, Courtemanche C, Karakla D et al. Analysis of transnasal endoscopic versus transseptal microscopic approach for excision of pituitary tumors. Am J Rhinol 2008; 22: 649-52.
6. Buchfelder M, Schlaffer S. Surgical treatment of pitu-itary tumours. Best Pract Res Clin Endocrinol Metab 2009; 23: 677-92.
7. Zhang Y, Wang Z, Liu Y, et al. Endoscopic transsphe-noidal treatment of pituitary adenomas. Neurol Res 2008; 30: 581-6.
8. Buchfelder M, Kreutzer J. Transcranial surgery for pi-tuitary adenomas.Pituitary 2008; 11: 375-84.
9. Fatemi N, Dusick JR, de Paiva et al. The endonasal microscopic approach for pituitary adenomas and other parasellar tumors: a 10 – year experience. Neurosurgery 2008; 63: 244-56.
10. Cappabianca P, Cavallo LM, de Divitiis O et al. Endo-scopic pituitary surgery. Pituitary 2008; 11: 385-90.
11. Zhou WG, Yang ZQ. Complications of transsphenoidal surgery for sellar region: intracranial vessel injury. Chin Med J 2009; 122: 1154-6.
12. Losa M, Gioia L, Picozzi P, Franzin A, Valle M, Gio-vanelli M, et al. The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary ade-noma. J Clin Endocrinol Metab 2008; 93: 2546-52.
13. Sangeetha SR, Singh N, Vender JR, Dhandapani KM. Suberoylanilide hydroxamic acid (SAHA) induces gro-wth arrest and apoptosis in pituitary adenoma cells. En-docrine 2009; 35: 389-96.
14. Nielsen EH, Lindholm J, Bjerre P, Christiansen JS, Ha-gen C, Juul S, et al. Frequent occurrence of pituitary apoplexy in patients with non-functioning pituitary ade-noma. Clin Endocrinol (Oxf) 2006; 64: 319-22.
15. Shahid K, Iqbal N. HRCT of pituitary fossa correlation of clinical and CT findings. Ann King Edward Med Coll 2007; 13: 48-50.
16. Mortini P, Losa M, Barzaghi R, Boari N, Giovanelli M. Results of transsphenoidal surgery in a large series of
patients with pituitary adenoma. Neurosurgery 2005; 56: 1222-33.
17. Nemergut EC. Perioperative management of patient undergoing transsphenoidal pituitary surgery. Anesth Analg 2005; 101: 1170-81.
18. Kristoe RA, Rother M, Neuloh G, Klingmaller D. Inci-dence, clinical manifestations, and course of water and electrolyte metabolism disturbances following trans-sphenoidal pituitary adenoma surgery: a prospective ob-servational study. J Neurosurg 2009; 111: 555-62.
19. Sudhakar N, Ray A, Vafidis JA. Complications after transsphenoidal surgery: our experience and a review of literature. Br J Neurosurg 2004; 18: 507-12.
20. Gondim JA, Schops M, de Almeida JP, de Albuquerque LA, Gomes E, Ferraz T, et al. Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pitui-tary adenomas treated in a pituitary center. Pituitary 2010; 13: 68-77.
21. Bernal S, Alobid I, Mullol J, Trobat F, Prekel M. Clo-sure of CSF leaks prevents ascending bacterial menin-gitis. 2005; 43: 277-81.
22. Baker F, Klibanski A, Swearigen B. transsphenoidal surgery for pituitary tumors in United States, 1996-2000: mortality, morbidity, and effects of hospital and surgeon volume. J Clin Endocrinol Metabol 2003; 88: 4709-19.

Downloads

Published

2018-11-04

Issue

Vol. 15 No. 2 (2011): July-December

Section

Original Articles

License

The work published by PJNS is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). Copyrights on any open access article published by Pakistan Journal of Neurological Surgery are retained by the author(s).